Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $128,483 | 12 | 82.1% |
| Travel and Lodging | $20,999 | 21 | 13.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,000 | 1 | 3.8% |
| Food and Beverage | $560.64 | 11 | 0.4% |
| Education | $450.73 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $117,330 | 14 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $20,644 | 28 | $0 (2018) |
| Daiichi Sankyo Inc. | $18,519 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $143,301 | 28 | Relypsa, Inc. ($110,289) |
| 2017 | $13,191 | 18 | Relypsa, Inc. ($7,041) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2018 | Daiichi Sankyo Inc. | Savaysa (Drug) | Consulting Fee | Cash or cash equivalent | $8,470.00 | General |
| Category: Thrombosis | ||||||
| 07/30/2018 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $30,170.00 | General |
| Category: Hyperkalemia | ||||||
| 07/12/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $202.25 | General |
| 07/12/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $68.96 | General |
| 06/04/2018 | Merck Sharp & Dohme Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| 06/04/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $195.16 | General |
| 06/04/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 05/25/2018 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $15,977.50 | General |
| Category: Hyperkalemia | ||||||
| 05/25/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Education | In-kind items and services | $450.73 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/25/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Travel and Lodging | In-kind items and services | $315.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/25/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Travel and Lodging | In-kind items and services | $268.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/25/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $95.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/24/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Travel and Lodging | In-kind items and services | $6,132.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/24/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Travel and Lodging | In-kind items and services | $268.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/24/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Travel and Lodging | In-kind items and services | $67.81 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/24/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/23/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Travel and Lodging | In-kind items and services | $268.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/07/2018 | Daiichi Sankyo Inc. | Savaysa (Drug) | Travel and Lodging | In-kind items and services | $9,593.41 | General |
| Category: Thrombosis | ||||||
| 05/07/2018 | Daiichi Sankyo Inc. | Savaysa (Drug) | Travel and Lodging | In-kind items and services | $274.80 | General |
| Category: Thrombosis | ||||||
| 05/06/2018 | Daiichi Sankyo Inc. | Savaysa (Drug) | Travel and Lodging | In-kind items and services | $181.25 | General |
| Category: Thrombosis | ||||||
| 04/06/2018 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $20,947.50 | General |
| Category: Hyperkalemia | ||||||
| 04/01/2018 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $103.59 | General |
| Category: Hyperkalemia | ||||||
| 03/05/2018 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $19,845.00 | General |
| Category: Hyperkalemia | ||||||
| 03/05/2018 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $7,228.00 | General |
| Category: Hyperkalemia | ||||||
| 01/22/2018 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $15,085.00 | General |
| Category: Hyperkalemia | ||||||
About Dr. Kevin Chan, M.D
Dr. Kevin Chan, M.D is a Nephrology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437330081.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Chan, M.D has received a total of $156,493 in payments from pharmaceutical and medical device companies, with $143,301 received in 2018. These payments were reported across 46 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($128,483).
Practice Information
- Specialty Nephrology
- Location Boston, MA
- Active Since 11/23/2007
- Last Updated 11/10/2011
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1437330081
Products in Payments
- Veltassa (Drug) $117,330
- Savaysa (Drug) $18,519
- ZEPATIER (Drug) $7,877
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Boston
David Friedman, M.d, M.D
Nephrology — Payments: $20.3M
Martin Pollak, Md, MD
Nephrology — Payments: $20.3M
Dr. Dennis Ausiello, Md, MD
Nephrology — Payments: $4.4M
Dr. Ajay Singh, Md, MD
Nephrology — Payments: $1.2M
Dr. Leslie Fang, Md, MD
Nephrology — Payments: $795,357
Dr. Jean Francis, M.d, M.D
Nephrology — Payments: $217,413